These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 5801059)

  • 61. [Effects of naftidrofuryl on the cerebral blood flow].
    Péchadre JC; Simard D
    Rev Neurol (Paris); 1974; 130(7-8):301-7. PubMed ID: 4453760
    [No Abstract]   [Full Text] [Related]  

  • 62. Blood flow in the calf muscles during walking: effect of daily muscular exercise in patients with occlusive arterial disease.
    Alpert J; Larsen OA; Lassen NA
    Scand J Clin Lab Invest Suppl; 1967; 100():90. PubMed ID: 6038162
    [No Abstract]   [Full Text] [Related]  

  • 63. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 64. [Rheographic studies and results of treatment with complamine (A contribution to the therapy of ulcus cruris "varicosum")].
    Kresbach H; Willingshofer H
    Z Haut Geschlechtskr; 1965 Jul; 39(1):14-22. PubMed ID: 5838624
    [No Abstract]   [Full Text] [Related]  

  • 65. The in vitro and in vivo effect of xanthinol niacinate on platelet aggregation, adhesion and blood coagulation.
    Balkuv S; Ulutin ON
    New Istanbul Contrib Clin Sci; 1967; 9(4):179-87. PubMed ID: 5609339
    [No Abstract]   [Full Text] [Related]  

  • 66. [Peripheral blood flow in hyperthyroidism measured with tissue clearance of Xe-133 with and without beta adrenergic blockade].
    Sieradzki J; Dubiel J; Szybiński Z
    Pol Tyg Lek; 1975 Jan; 30(3):97-9. PubMed ID: 1110956
    [No Abstract]   [Full Text] [Related]  

  • 67. [Treatment of degenerative diseases of the retina with progresin retard].
    Schaaf G
    Munch Med Wochenschr; 1970 Mar; 112(10):433-6. PubMed ID: 5537870
    [No Abstract]   [Full Text] [Related]  

  • 68. [Demonstration of effect of vasoactive substances by infrared thermography].
    Harders H; Tilsner V; Heisig N; Haan D
    Med Klin; 1967 Apr; 62(14):566-7. PubMed ID: 5599931
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of plasminogen activator present in the endothelium of venous vessels on the development of thrombotic diseases].
    Czestochowska E
    Pol Tyg Lek; 1974 Apr; 29(14):587-9. PubMed ID: 4828036
    [No Abstract]   [Full Text] [Related]  

  • 70. The use of 133Xe clearance method in measurement of the blood flow in thyroid nodules.
    Rekonen A; Kuikka J; Isomäki AM; Norkman E
    Ann Clin Res; 1973 Aug; 5(4):220-4. PubMed ID: 4771299
    [No Abstract]   [Full Text] [Related]  

  • 71. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age].
    Giovanardi F; Bisceglia G
    Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003
    [No Abstract]   [Full Text] [Related]  

  • 72. [The effect of the local anesthetic HOE 40045 on the circulation of subcutaneous and muscle tissue: determination with xenon-133 (author's transl)].
    Larsen B; Thyregod P
    Prakt Anaesth; 1974 Jun; 9(3):188-91. PubMed ID: 4459910
    [No Abstract]   [Full Text] [Related]  

  • 73. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 74. [Use of radioactive xenon (133Xe) for the studies on the effect of glucose and insulin on the rest blood flow. I. Tissue clearance method with application of radioactive xenon (133Xe)].
    Graban W
    Pol Przegl Radiol Med Nukl; 1969; 33(5):691-7. PubMed ID: 5360938
    [No Abstract]   [Full Text] [Related]  

  • 75. [Concussion of the brain and its treatment in organically changed capillary vessels with hexanitol].
    Richard A
    Med Welt; 1968 Sep; 37():1995-7. PubMed ID: 5712122
    [No Abstract]   [Full Text] [Related]  

  • 76. Venous occlusion and xenon 133 muscle clearance.
    Weber TR; Lindenauer SM; Pozderac RV; Freedman W; Fry WJ
    Surg Forum; 1974; 25(0):260-2. PubMed ID: 4439183
    [No Abstract]   [Full Text] [Related]  

  • 77. [Muscle blood flow determination with radioactive xenon (133Xe) in cases of primary muscular dystrophy].
    Kapuścińska B; Kapuściński A; Stroińska B
    Neurol Neurochir Pol; 1969; 3(5):601-6. PubMed ID: 5358740
    [No Abstract]   [Full Text] [Related]  

  • 78. 133-Xenon tests for evaluating obliterative arterial disease.
    Lindbjerg IF
    Scand J Clin Lab Invest Suppl; 1967; 100():77. PubMed ID: 6038157
    [No Abstract]   [Full Text] [Related]  

  • 79. New method for measuring regional cerebral blood flow and blood volume in man using the gamma camera.
    Mathew NT; Meyer JS; Bell RL; Ericsson AD
    Trans Am Neurol Assoc; 1971; 96():273-5. PubMed ID: 5159105
    [No Abstract]   [Full Text] [Related]  

  • 80. Prediction of tissue loss in experimental frostbite with radioactive xenon.
    Summer DS; Criblez TL; Novak JK; Doolittle WH
    Surg Gynecol Obstet; 1970 Sep; 131(3):417-23. PubMed ID: 5460434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.